Michael C. Greiner is the Chief Financial Officer and Chief Transformation Officer at Avanos Medical, Inc., where he plays a key role in guiding the company's financial strategies and growth. Since joining Avanos in 2020, he has been instrumental in...

Current Market Cap

$817.09M

Number of Employees

3.77K

Total Compensation

2020 - 2023

Trending up by 33.76% last year
Showing total compensation for the last 2020 - 2023

Stock

Up by 0.00% last year

Salary

Down by -24.02% last year

Bonus

Up by 0.00% last year

Other

Down by -100.00% last year

Year

2023

Total Compensation

$723.26K

Salary

$390.25K

Board Justification

The compensation program is designed to align executive pay with performance metrics that drive company success, ensuring that compensation reflects both individual and company performance.

Bonus

$333.01K

Board Justification

Annual cash incentive payout based on performance metrics achieved in 2023, resulting in an 84.7% payout percentage.

Other

$0.00

Board Justification

No additional compensation reported outside of salary, bonus, and stock awards.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock was vested in 2023 as the focus was on performance-based awards that will vest in future years.

Performance Metrics

Performance metrics for 2023 included adjusted net sales, adjusted EBITDA, and strategic initiatives.

SEC Filing

From March 15, 2024

Michael C. Greiner

CEO of Avanos Medical

A

Education

Not specified

Field of Expertise

Finance & Banking - Finance

Born

January 1, 1972 - 52 years ago

Is Founder?

No

Current Tenure

0 years 0 months (Oct 2024 - Present)

Previous Experience

CFO at AngioDynamics, Inc.